rAAV-Olig001-ASPA, Levetiracetam, Prednisone — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-08-31 in 2mo
ESTIMATED |
READOUT
rAAV-Olig001-ASPA Gene Therapy for Treatment of Children With Typical Canavan Di
Phase 1/2 · Canavan Disease |
Myrtelle Inc. | rAAV-Olig001-ASPA, Levetiracetam, Predni |
ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
|